Cleave Therapeutics

Developer of VCP/p97 inhibitors for oncology and neurodegenerative diseases

placeSan Francisco, California, United States calendar_todayFounded 2010 groups18 employees language cleavetherapeutics.com

Registered entities

Innovation

3 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 29 times.

YearFilings
20212
20222
20233
20242

Investor mix

12 investors on record; lead investors include Nextech Invest, Arcus Ventures, 5AM Ventures, Blackstone.

Investor typeCountShare
Venture capital758%
Private equity325%
Other / undisclosed217%
Coming soon